In India, with increasing demand for PT, aPTT, Fibrinogen & D-Dimer tests, many labs are investing in coagulation analyzers. But surprisingly, most small and mid-size labs still repeat 7 critical mistakes while choosing or using these analyzers — leading to higher costs, errors, and poor patient reporting.
TIP: Semi-automated coagulation analysers like FibriTimer Zeta-1
Best Practice: Opt for Open System Analyzers (like Operon’s range) supporting validated, affordable multi reagent brands.
Many labs regret buying analyzers without dual clot detection (Mechanical + Optical).
Solution: FibriTimer Zeta-1 with patented Dual Technology ensures accurate reporting even with difficult samples.
Advantage: FibriTimer Zeta-1 comes with 4-5 hours in-built UPS backup for uninterrupted operations.
Smart Move: Start with semi-automated analyzers like Zeta Series. Upgrade later if required.
Why Operon Stands Out: Pan-India service support, training from coagulation experts, and lab QC guidance.
Operon Biotech Advantage: Indigenous design, affordable pricing, and customized features for Indian labs.
Buying a coagulation analyzer is a long-term investment. Avoid these 7 mistakes and choose wisely.
Explore Operon’s trusted solutions:
Visit: www.operonbiotech.com
In modern healthcare, automated coagulation analyzers are transforming blood clot management by providing highly accurate, rapid, and efficient diagnostics. These devices play a pivotal role in diagnosing and managing bleeding disorders, thrombosis, and anticoagulation therapy—ensuring timely treatment and improved patient outcomes.
Coagulation testing assesses the blood’s ability to clot, aiding in the diagnosis and monitoring of various conditions, such as:
Modern coagulation analyzers process large sample volumes with minimal manual intervention, ensuring efficiency and accuracy in high-throughput labs.
Advanced devices conduct a range of coagulation tests, including:
Innovative analyzers, like FibriTimer Zeta-1, incorporate mechanical and optical clot detection. This dual technology enhances test accuracy, minimizes false readings, and ensures reliable results even with challenging samples (e.g., turbid or hemolyzed specimens).
Modern analyzers feature intuitive touchscreen interfaces, LIS connectivity, and remote access capabilities for seamless lab integration and efficient data management.
Automated analyzers adhere to strict quality control protocols, utilizing built-in Westgard rules and real-time monitoring to ensure consistent and reproducible results.
Healthcare facilities, ranging from small clinics to large hospitals, require accurate and timely coagulation reports for pre-surgical screening, emergency management, and chronic disease monitoring. High-performance analyzers provide the reliability needed for critical patient care.
When selecting a coagulation analyzer, consider:
Emerging trends in coagulation diagnostics include:
Operon Biotech has earned a strong reputation in coagulation diagnostics by offering high-quality, innovative, and cost-effective solutions. With years of industry expertise, the company delivers:
Automated coagulation analyzers are redefining hematology diagnostics, offering unmatched precision, efficiency, and speed. Whether for high-throughput hospital labs or mid-sized clinical settings, investing in a cutting-edge coagulation testing system ensures better patient outcomes, reduced errors, and cost-effective operations.
With FibriTimer Zeta-1, healthcare providers gain access to patented dual technology, ensuring fast, accurate, and reliable results—paving the way for the future of precision blood clot management.
For more insights into the latest coagulation advancements, Reach out to Operon Biotech team at info@operonbiotech.com
Disclaimer : This content may be copyright protected. Reproduction, modification, or use without prior written permission is prohibited.
Questions/ Feedback? We’d love to hear from you! Feel free to write to us on info@dfinebio.in or comment in the section below.
